This website is intended for healthcare professionals only

Trending Topic

AI generated heart image pink purple and blue
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Duchenne muscular dystrophy (DMD) is an X-linked myopathy resulting from inactivating dystrophin mutations that cause progressive muscle breakdown, affecting 1:5,000 live male births globally. Boys with DMD are typically diagnosed at ~4 years of age, lose ambulation as preteens and die of respiratory or heart failure by their third decade. With modern respiratory support, cardiac […]

Search Results

168 Results Found for “community”

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
AI generated heart image pink purple and blue
Mark CompleteCompleted
BookmarkBookmarked

Duchenne muscular dystrophy (DMD) is an X-linked myopathy resulting from inactivating dystrophin mutations that cause progressive muscle breakdown, affecting 1:5,000 live male births globally. Boys with DMD are typically diagnosed at ~4 years of age, lose ambulation as preteens and die of ...

Mark CompleteCompleted
BookmarkBookmarked

Dr Kamilė Čerlinskaitė-Bajorė is a cardiologist and touchCARDIO Future Leader 2026. In this interview, she discusses her journey into cardiology and heart failure, the mentors who have shaped her career, the challenges of caring for complex patients, and the importance of resilience and support from colleagues. She also shares her enthusiasm for advances in heart failure treatment and emerging research into heart failure with preserved ejection fraction.

Mark CompleteCompleted
BookmarkBookmarked

Dr Aldostefano Porcari is a Consultant Cardiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiology, the mentors and experiences that shaped his career, the clinical reasoning that drives his interest in complex cases, and the importance of understanding your strengths and finding a specialty that aligns with who you are.

Mark CompleteCompleted
BookmarkBookmarked

Meet the cardiologists shaping the future of the specialty. Our touchCARDIO Future Leaders 2026 are rising stars nominated by the cardiology community for their contributions to research, clinical practice and innovation. Discover the clinicians and researchers challenging convention, advancing care and driving progress across cardiology.

Mark CompleteCompleted
BookmarkBookmarked

Dr Maxime Caru is a pediatric exercise physiologist, researcher and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardio-oncology, the mentors who shaped his career, the role of physical activity in reducing treatment-related cardiotoxicity in pediatric cancer survivors and his vision for integrating exercise and supportive care into standard pediatric oncology practice.

Mark CompleteCompleted
BookmarkBookmarked

Dr Arunashis Sau is a cardiologist, electrophysiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into electrophysiology, the mentors who shaped his career, combining clinical training with research, and his work using artificial intelligence to unlock new insights from ECGs and other clinical data.

Mark CompleteCompleted
BookmarkBookmarked

Dr Abhishek Chaturvedi is a cardiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiology, the mentors and experiences that shaped his career, his passion for interventional cardiology and cardiovascular research, and the importance of combining clinical excellence, scientific discovery and global health initiatives to improve patient outcomes.

Mark CompleteCompleted
BookmarkBookmarked

Dr Alfredo Caturano is an Assistant Professor of Internal Medicine and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiovascular and cardiometabolic medicine, the mentors who shaped his career, the challenges and rewards of clinical research, and the evolving links between diabetes, obesity and cardiovascular disease, as well as his vision for more personalised approaches to cardiometabolic care.

Mark CompleteCompleted
BookmarkBookmarked

Dr Faisal Rahman is an interventional structural cardiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiology, the mentors and role models who shaped his career, the rewards of caring for complex patients and developing trainees, and his vision for advancing cardiogenic shock, structural heart disease, research and education.

Mark CompleteCompleted
BookmarkBookmarked

Dr Ushasi Saraswati is a physician specialising in cardiovascular medicine and touchCARDIO Future Leader 2026. In this interview, she discusses her journey into cardiology, the mentors who shaped her approach to medicine, the rewarding experience of caring for a patient with a complex diagnosis, and the importance of combining scientific curiosity and clinical expertise with compassion, clear communication and a commitment to patient-centred care.

Mark CompleteCompleted
BookmarkBookmarked

Dr Vijay Shyam-Sundar is a cardiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiology and clinical academia, the mentors who shaped his career, the challenges of research funding, and his work developing artificial intelligence to improve cardiovascular care, as well as his vision for the safe, explainable and effective use of AI in clinical practice.

Mark CompleteCompleted
BookmarkBookmarked

The first dedicated ESC Guidelines on the management of cardiovascular disease and chronic kidney disease recommend kidney function and urine albumin testing in all patients with cardiovascular disease, with an emphasis on identifying CKD early and initiating effective treatment without delay.

Mark CompleteCompleted
BookmarkBookmarked

Dr Arasi Maran explores practical strategies for integrating lifestyle interventions into the management of complex coronary artery disease, including how to prioritise modifiable risk factors, communicate recommendations effectively and support sustained behaviour change. She also discusses the role of imaging, reliable health information and patient-centred approaches to improving adherence.

Mark CompleteCompleted
BookmarkBookmarked
Coverage from: ESC Highlights

Late-breaking clinical research will once again be a major focus at ESC Congress 2026, taking place in Munich, Germany, from August 28–31. This year, a record 59 trials have been selected for presentation across 12 Hot Line sessions, spanning new pharmacological approaches, diagnostic strategies, devices, imaging and digital technologies.

Mark CompleteCompleted
BookmarkBookmarked
Coverage from: ESC Highlights

New clinical guidelines, late-breaking trials, artificial intelligence, and an increasing focus on cardiometabolic and precision medicine are set to shape discussions at ESC Congress 2026 in Munich.

Mark CompleteCompleted
BookmarkBookmarked

A new World Heart Federation (WHF) Roadmap proposes a broader, more adaptable model of cardiac rehabilitation designed to support people with cardiovascular disease over the long term.

Mark CompleteCompleted
BookmarkBookmarked

Ionis Pharmaceuticals (Carlsbad, CA, USA) and AstraZeneca (Cambridge, UK) have announced that the phase 3 CARDIO-TTRansform trial (NCT04136171) of eplontersen (Wainua®; Ionis Pharmaceuticals and AstraZeneca) did not meet its primary efficacy endpoint in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM).

Futuristic medical research of heart cardiology health care with vitals, diagnosis biometrics scan, catheter services, stethoscope. Artificial intelligence
Mark CompleteCompleted
BookmarkBookmarked

At EHRA 2026, Professor Claudio Tondo presents his highlights on advances in ablation and device technologies, led by pulsed field ablation, showcasing a rapidly evolving landscape in the treatment of complex arrhythmias.

Load More...
Close Popup